3,7-dimethyl-1-propargylxanthine has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (63.89) | 18.2507 |
2000's | 13 (36.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Ribeiro, JA; Sebastião, AM | 1 |
Cano, C; Malik, KU | 1 |
Hedlund, PB; Hillefors-Berglund, M; von Euler, G | 1 |
Chiang, CP; Chiang, PH; Huang, CH; Shen, MR; Tsai, EM; Wu, CC; Wu, SN | 1 |
Boyet, S; Daval, JL; Nehlig, A | 1 |
Barraco, RA; Martens, KA; Normile, HJ; Parizon, M | 2 |
de Carolis, AS; Pèzzola, A; Popoli, P | 1 |
Haynes, JM; Pennefather, JN | 1 |
Doak, GJ; Sawynok, J | 1 |
Kaneko, S; Mizuno, K; Okada, M | 1 |
Ling, BN; Ma, H | 1 |
Bong, GW; Firestein, GS; Rosengren, S | 1 |
Abe, T; Gutterman, DD; Morgan, DA | 1 |
Chen, J; Dinger, B; Fidone, SJ | 1 |
Ji, T; Kessey, K; Mogul, DJ; Overstreet, LS; Trommer, BL | 1 |
Kim, YH; Song, DK; Suh, HW | 1 |
Frobenius, W; Geis, U; Hipp, J; Müller, CE; Pawłowski, M; Sandoval-Ramírez, J; Schobert, U; Suzuki, F | 1 |
Kaneko, S; Kawata, Y; Kondo, T; Mizuno, K; Murakami, T; Okada, M; Wada, K | 1 |
Jurklies, B; Kaelin-Lang, A; Niemeyer, G | 1 |
Burnside, B; Rey, HL | 1 |
Baldo, BA; Koob, GF; Markou, A | 1 |
Agostinho, P; Caseiro, P; Cunha, RA; Duarte, EP; Oliveira, CR; Rego, AC | 1 |
Capasso, A | 1 |
O'Sullivan, RG; Redmond, HP; Street, JT; Wakai, A; Wang, JH; Winter, DC | 1 |
Chandilawa, R; Dagar, S; Gao, XP; Hong, D; Rubinstein, I | 1 |
Correia-de-Sá, P; Ribeiro, JA; Timóteo, MA | 1 |
Hamann, M; Richter, A | 1 |
Håberg, A; Hammer, J; Qu, H; Sonnewald, U | 1 |
Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T; Yamagiwa, T | 1 |
Belem, PC; Chen, JF; Cronstein, B; Elson, G; Fink, JS; Jacobson, M; Leibovich, SJ; Montesinos, C; Pinhal-Enfield, G; Ramanathan, M; Rosania, A; Schwarzschild, MA | 1 |
Diniz, C; Gonçalves, J; Leal, S | 1 |
Chaimovitz, C; Douvdevani, A; Mazar, J; Nakav, S; Rogachev, B; Ziv, NY; Zlotnik, M | 1 |
Belardinelli, L; Chu, N; Diamond, I; Kalla, R; Leung, K; Shryock, JC; Soelaiman, S; Soohoo, D; Yang, M; Yao, L; Zablocki, J | 1 |
Capasso, A; Gallo, C | 1 |
1 review(s) available for 3,7-dimethyl-1-propargylxanthine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
1 trial(s) available for 3,7-dimethyl-1-propargylxanthine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
Article | Year |
---|---|
Adenosine modulation of neurotransmission in penile erection.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Aged; Alprostadil; Animals; Antihypertensive Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Norepinephrine; Penile Erection; Penis; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Rabbits; Synaptic Transmission; Theobromine; Vasodilator Agents | 1994 |
34 other study(ies) available for 3,7-dimethyl-1-propargylxanthine and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
Article | Year |
---|---|
Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus.
Topics: Adenosine; Animals; Evoked Potentials; Hippocampus; In Vitro Techniques; Male; Phenethylamines; Pyramidal Tracts; Rats; Rats, Wistar; Receptors, Purinergic; Theobromine; Time Factors | 1992 |
Adenosine receptor-mediated alterations in prostacyclin production and cardiac function in the isolated rabbit heart.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Epoprostenol; Heart; Heart Rate; Male; Myocardial Contraction; Myocardium; Phenethylamines; Rabbits; Receptors, Purinergic; Theobromine | 1992 |
Effects of CGS 21680 in vivo on dopamine D2 agonist binding in the rat brain.
Topics: Adenosine; Animals; Antipsychotic Agents; Male; Phenethylamines; Prosencephalon; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Purinergic P1; Theobromine | 1995 |
Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain.
Topics: Adenosine; Animals; Blood Pressure; Brain; Cochlea; Deoxyglucose; Energy Metabolism; Glucose; Male; Phenethylamines; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theobromine; Xanthines | 1994 |
Role of adenosine A2a receptors in the nucleus accumbens.
Topics: Adenosine; Animals; Dose-Response Relationship, Drug; Injections; Male; Mice; Mice, Inbred ICR; Motor Activity; Nucleus Accumbens; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine | 1994 |
Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats.
Topics: Adenosine; Animals; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dopamine; Injections, Intraperitoneal; Male; Phenethylamines; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Synaptic Transmission; Theobromine; Theophylline | 1994 |
A1- and A2-purinoceptors in the guinea-pig uterus.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cyclic AMP; Dose-Response Relationship, Drug; Endometrium; Female; Guinea Pigs; In Vitro Techniques; Myometrium; Phenethylamines; Phenylephrine; Phenylisopropyladenosine; Radioligand Assay; Receptors, Purinergic; Theobromine; Uterine Contraction; Xanthines | 1993 |
Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antihypertensive Agents; Depression, Chemical; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Microinjections; Motor Activity; Nucleus Accumbens; Phenethylamines; Receptors, Purinergic; Theobromine; Vasodilator Agents | 1993 |
Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat.
Topics: Adenosine; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Formaldehyde; Injections, Subcutaneous; Male; Nociceptors; Phenethylamines; Rats; Rats, Sprague-Dawley; Theobromine; Time Factors | 1995 |
Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum.
Topics: Adenosine; Animals; Antihypertensive Agents; Caffeine; Camptothecin; Dopamine; Enzyme Inhibitors; Extracellular Space; Irinotecan; Male; Microdialysis; Neostriatum; Phenethylamines; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine; Vasodilator Agents | 1996 |
Luminal adenosine receptors regulate amiloride-sensitive Na+ channels in A6 distal nephron cells.
Topics: Adenosine; Amiloride; Cell Line; Dose-Response Relationship, Drug; Nephrons; Patch-Clamp Techniques; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Sodium Channels; Theobromine; Xanthines | 1996 |
Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anti-Inflammatory Agents; Carrageenan; Catheterization; Central Nervous System; Dexamethasone; Excitatory Amino Acid Antagonists; Inflammation; N-Methylaspartate; Neutrophils; Peroxidase; Phenethylamines; Propionates; Purinergic P1 Receptor Antagonists; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Signal Transduction; Skin; Spinal Cord; Theobromine | 1996 |
Role of adenosine receptor subtypes in neural stunning of sympathetic coronary innervation.
Topics: Adenosine; Animals; Coronary Vessels; Dogs; Female; Male; Myocardial Stunning; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Sympathetic Nervous System; Theobromine; Theophylline; Vasoconstriction; Xanthines | 1997 |
cAMP production in rabbit carotid body: role of adenosine.
Topics: Adenosine; Animals; Carotid Body; Cyclic AMP; Dipyridamole; Hypoxia; In Vitro Techniques; Phenethylamines; Purinergic P1 Receptor Antagonists; Rabbits; Theobromine; Xanthines | 1997 |
A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus.
Topics: Adenosine; Animals; Hippocampus; Long-Term Potentiation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synaptic Transmission; Theobromine; Theophylline | 1997 |
Differential effects of adenosine receptor antagonists injected intrathecally on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the mouse.
Topics: Adenosine; Analgesics; Animals; beta-Endorphin; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Morphine; Phenethylamines; Purinergic P1 Receptor Antagonists; Reaction Time; Theobromine; Xanthines | 1997 |
Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Topics: Adenosine; Animals; Binding, Competitive; Brain; Caffeine; Molecular Structure; Phenethylamines; Protein Binding; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Theobromine; Xanthines | 1997 |
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
Topics: Adenosine; Animals; Antihypertensive Agents; Biological Transport; Caffeine; Central Nervous System Stimulants; Fluoxetine; Hippocampus; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quipazine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Theobromine; Theophylline; Vasodilator Agents | 1999 |
Effects of adenosinergic agents on the vascular resistance and on the optic nerve response in the perfused cat eye.
Topics: Adenosine; Animals; Cats; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Electrophysiology; Female; Optic Nerve; Perfusion; Phenethylamines; Photic Stimulation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Retina; Theobromine; Theophylline; Vascular Resistance | 1999 |
Adenosine stimulates cone photoreceptor myoid elongation via an adenosine A2-like receptor.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Cell Size; Cells, Cultured; Darkness; Light; Neuroprotective Agents; Perciformes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Retinal Cone Photoreceptor Cells; Theobromine | 1999 |
Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.
Topics: Adenosine; Animals; Brain; Caffeine; Cocaine; Differential Threshold; Dopamine Uptake Inhibitors; Drug Interactions; Electric Stimulation; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Receptors, Purinergic P1; Reference Values; Reward; Substance Withdrawal Syndrome; Theobromine | 1999 |
Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
Topics: Adenosine; Adenosine Deaminase; Animals; Ascorbic Acid; Aspartic Acid; Calcium; Cells, Cultured; Chick Embryo; Drug Synergism; Kinetics; Oxidative Stress; Phenethylamines; Potassium; Potassium Chloride; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Purinergic P1; Retina; Theobromine; Tritium; Xanthines | 2000 |
Adenosine receptors are involved in the control of acute naloxone-precipitated withdrawal: in vitro evidence.
Topics: Adenosine; Animals; Caffeine; Dipyridamole; Guinea Pigs; Ileum; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2000 |
Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); CD18 Antigens; Cell Movement; Cells, Cultured; Chemotaxis, Leukocyte; Depression, Chemical; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Humans; Intercellular Adhesion Molecule-1; Lymphokines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Theobromine; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Adenosine A(1) receptors mediate plasma exudation from the oral mucosa.
Topics: Adenosine; Animals; Bradykinin; Cricetinae; Dextrans; Exudates and Transudates; Fluorescein-5-isothiocyanate; Indomethacin; Male; Mesocricetus; Mouth Mucosa; NG-Nitroarginine Methyl Ester; Nitroglycerin; Phenethylamines; Phenylisopropyladenosine; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theobromine; Xanthines | 2001 |
Synergism between A(2A)-adenosine receptor activation and vasoactive intestinal peptide to facilitate [3H]-acetylcholine release from the rat motor nerve terminals.
Topics: Acetylcholine; Adenosine; Adenosine Deaminase; Animals; Antihypertensive Agents; Diaphragm; Drug Synergism; Female; Male; Motor Neurons; Phenethylamines; Phrenic Nerve; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Synaptic Transmission; Theobromine; Tritium; Vasoactive Intestinal Peptide | 2001 |
Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
Topics: Adenosine; Animals; Caffeine; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Female; Male; Mesocricetus; Muscle Contraction; Mutation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Theobromine; Theophylline; Triazines; Triazoles; Xanthines | 2001 |
In vivo effects of adenosine A(2) receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo (13)C MR spectroscopy.
Topics: Acetates; Adenosine; Amino Acids; Animals; Cerebral Cortex; Glucose; Magnetic Resonance Spectroscopy; Male; Neurons; Phenethylamines; Prefrontal Cortex; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine | 2001 |
Activation of adenosine A2a receptor pathway reduces leukocyte infiltration but enhances edema formation in rat caerulein pancreatitis.
Topics: Adenosine; Amylases; Animals; Ceruletide; Edema; Leukocytes; Male; Pancreatitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine | 2002 |
Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blotting, Western; Cells, Cultured; Drosophila Proteins; Endothelial Growth Factors; Female; Interferon-gamma; Lipopolysaccharides; Lymphokines; Macrophages, Peritoneal; Male; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenethylamines; Protein Kinase Inhibitors; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2A; Receptors, Cell Surface; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Theobromine; Toll-Like Receptor 4; Toll-Like Receptors; Triazines; Triazoles; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xanthines | 2002 |
Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens.
Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Epididymis; Immunohistochemistry; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Phenethylamines; Prostate; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theobromine; Triazines; Triazoles; Vas Deferens; Xanthines | 2003 |
Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Antihypertensive Agents; Cells, Cultured; Disease Models, Animal; Down-Regulation; Epithelium; Escherichia coli; Female; Humans; Inflammation; Interleukin-6; Leukocytes; Mice; Mice, Inbred Strains; Peritonitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Purinergic P1; RNA, Messenger; Theobromine; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthines | 2006 |
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Animals; Binding, Competitive; Biological Availability; Cell Line; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Male; Metabolic Clearance Rate; Molecular Structure; PC12 Cells; Phenethylamines; Purines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Theobromine; Triazines; Triazoles; Xanthines | 2007 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |